Drug metabolism in the lungs: opportunities for optimising inhaled medicines. (2021)
Attributed to:
Component-Specific Air pollutant Drivers of Disease Risk in Early to Midlife: a pathway approach. (DREaM)
funded by
UKRI
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/17425255.2021.1908262
PubMed Identifier: 33759677
Publication URI: http://europepmc.org/abstract/MED/33759677
Type: Journal Article/Review
Volume: 17
Parent Publication: Expert opinion on drug metabolism & toxicology
Issue: 5
ISSN: 1742-5255